Stocks / BIOMERIEUX
Stock profile

BIOMERIEUX

BIM.PA · FR0013280286 · Euronext Paris
Healthcare · Diagnostics & Research
SBF 120MSCI World ranking
Latest daily close
93.30 EUR
-1.53%
Data as of 6 November 2026 · Volume 179,226
3-month Momentum · SBF 120
91.04
Rank #1 / 120
Solidity
68.72
15 sector-relative components
Market regime · SBF 120
Pending
Shown after production-rule validation

Performance

Total returns calculated from adjusted daily closing prices.

1 day-1.53%
1 week+3.09%
1 month+12.14%
3 months+27.81%
6 months+28.25%
YTD-14.25%
1 year-11.19%
3 years+3.71%
5 years-6.41%
Full history+668.12%

Momentum rankings

Scores are relative to each universe. M0, M-1 and M-2 each carry 33.33%; volatility has a 0% score weight.

PeriodUniverseRankTotal scoreM0 perf. / scoreM-1 perf. / scoreM-2 perf. / scoreAnnualized vol.Data date
1 MonthSBF 120#11 / 12070.87+2.53% / 39.50+4.78% / 85.71+7.42% / 87.3942.82%6 November 2026
1 MonthMSCI Worldranking universe#276 / 128262.27+3.15% / 76.52-0.27% / 54.62+2.02% / 55.6520.89%28 August 2026
3 MonthsSBF 120#1 / 12091.04+16.48% / 89.08+7.30% / 95.80+2.97% / 88.2427.00%6 November 2026
3 MonthsMSCI Worldranking universe#717 / 128247.80+0.60% / 49.49+5.19% / 57.48-1.39% / 36.4226.57%28 August 2026
6 MonthsSBF 120#9 / 12072.27+24.98% / 99.16+7.33% / 73.11-0.77% / 44.5426.54%6 November 2026
6 MonthsMSCI Worldranking universe#1061 / 128235.90+5.82% / 54.84+3.48% / 52.14-30.20% / 0.7130.11%28 August 2026
1 YearSBF 120#95 / 12040.34+34.15% / 95.80-26.10% / 5.04-9.49% / 20.1728.07%6 November 2026
1 YearMSCI Worldranking universe#1170 / 128226.17+9.51% / 56.05-36.55% / 1.19-6.62% / 21.2629.84%28 August 2026
Ranking universes: MSCI World appears in the Momentum datasets but is not yet recorded as an official membership in the central registry.

Technical analysis

One year of adjusted prices with moving averages and daily volume.

118.84104.8290.7976.7662.73Nov 2025May 2026Nov 2026
Adjusted priceSMA 20SMA 50SMA 200Volume bars
SMA 2089.44
SMA 5081.12
SMA 20080.07
RSI 1466.16
MACD3.854
MACD signal3.646
MACD histogram0.207
ATR 142.68%

Fundamental solidity

Five weighted pillars built from 15 sector-relative percentile indicators.

Valuation · 10%77.71
Profitability · 30%67.29
Balance sheet · 20%86.74
Growth · 15%42.36
Cash flow · 25%68.24
PillarIndicatorValueScoreComparison
ValuationTrailing P/E19.35x90.91Sector · Healthcare
ValuationForward P/E16.17x57.14Sector · Healthcare
ValuationEV / EBITDA8.23x91.67Sector · Healthcare
ProfitabilityProfit margin11.59%82.35Sector · Healthcare
ProfitabilityOperating margin15.23%58.82Sector · Healthcare
ProfitabilityReturn on assets7.23%70.59Sector · Healthcare
ProfitabilityReturn on equity11.22%60.00Sector · Healthcare
Balance SheetDebt / equity9.81%87.50Sector · Healthcare
Balance SheetNet debt / EBITDA-0.22x91.67Sector · Healthcare
Balance SheetCurrent ratio2.30x82.35Sector · Healthcare
Balance SheetQuick ratio1.44x76.47Sector · Healthcare
GrowthRevenue growth-3.90%18.75Sector · Healthcare
GrowthEarnings growth41.90%77.78Sector · Healthcare
CashflowFree cash flow margin14.77%70.59Sector · Healthcare
CashflowOperating cash flow margin22.68%64.71Sector · Healthcare

Risk and market behaviour

Risk

Volatility · 21 sessions
28.24%
Volatility · 60 sessions
24.32%
Volatility · 252 sessions
30.71%
Maximum drawdown · 1 year
-41.19%
Maximum drawdown · 5 years
-47.38%
Current drawdown from ATH
-31.26%
Distance from 52-week high
-18.53%
52-week range position
56.61%

Trading sessions · 1 year

Positive sessions
50.00%
Average positive session
+1.26%
Average negative session
-1.35%
Best session
+6.01%
Worst session
-17.46%
Longest rising streak
9 sessions
Longest falling streak
7 sessions
Average monthly return
-0.61%

Fundamentals and dividends

Key fundamentals

Market capitalization
8,879,867,379
Enterprise value
8,651,952,128
Trailing P/E
19.35
Forward P/E
16.17
EV / EBITDA
8.23
Profit margin
11.59%
Operating margin
15.23%
Revenue growth
-3.90%
Net debt
-235,899,968

Dividends and consensus

Last dividend date
9 June 2026
Last dividend per share
0.98 EUR
Trailing 12-month dividend
0.98 EUR
Trailing dividend yield
1.05%
Analyst target mean
79.04 EUR
Analyst count
14
Market regime: the SBF 120 field remains intentionally pending until the production trend rule is validated. No investment signal is inferred.

MarketMoveForecast rankings, statistics and indicators are provided for information and educational purposes only. They do not constitute investment advice. Market data may contain delays, omissions or errors, and past performance does not guarantee future results.